Evidence map›Paper›PMID 31658976›Full record

SynthesisDiabetes care2020

Vertebral Fractures in Individuals With Type 2 Diabetes: More Than Skeletal Complications Alone.

Fjorda Koromani, Ling Oei, Enisa Shevroja, Katerina Trajanoska, Josje Schoufour, Taulant Muka, Oscar H Franco, M Arfan Ikram, M Carola Zillikens, André G Uitterlinden and 13 more

Open access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Diabetes care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it, 146 citations in OpenAlex.

  1. Pooled it
  2. Diabetes Mellitus and the Benefit of Antiresorptive Therapy on Fracture Risk.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Role of microRNA in Diabetic Osteoporosis.Molecular biotechnology · 2025
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 4 countries.

Fjorda KoromaniDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Ling OeiDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Enisa ShevrojaBone and Joint Department, Center of Bone Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Katerina TrajanoskaDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Josje SchoufourDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Taulant MukaDepartment of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Oscar H FrancoDepartment of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.
M Arfan IkramDepartment of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
M Carola ZillikensDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
André G UitterlindenDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Gabriel P KrestinDepartment of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Tassos AnastassiadesDivision of Rheumatology, Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Robert JosseDivision of Endocrinology and Metabolism, University of Toronto, Toronto, Ontario, Canada.
Stephanie M KaiserDepartment of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
David GoltzmanDepartment of Medicine, McGill University, Montreal, Quebec, Canada.
Brian C LentleDepartment of Radiology, University of British Columbia, Vancouver, British Columbia, Canada.
Jerilynn C PriorEndocrinology, Department of Medicine, University of British Columbia, Vancouver, Canada.
William D LeslieDepartment of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-1056-1691
Eugene McCloskeyThe Mellanby Centre for Bone Research, University of Sheffield, Sheffield, U.K.
Olivier LamyBone and Joint Department, Center of Bone Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Didier HansBone and Joint Department, Center of Bone Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Edwin H OeiDepartment of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Fernando RivadeneiraDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands f.rivadeneira@erasmusmc.nl.ORCID 0000-0001-9435-9441
Erasmus MC · NLUniversity of Lausanne · CHUniversity of British Columbia · CADalhousie University · CAMcGill University · CAQueen's University · CAUniversity of Manitoba · CAUniversity of Sheffield · GBUniversity of Toronto · CA

Funding

Study of Osteoporotic FracturesR01AG005407 · NIA · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI CUMMINGS, STEVEN RON, YAFFE, KRISTINE · 1986 to 2016
$23.2M
Study of Osteoporotic FracturesR01AG005394 · NIA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ENSRUD, KRISTINE · 1986 to 2015
$6.1M
STUDY OF OSTEOPOROTIC FRACTURES: VERTEBRAL FRACTURESR01AR035583 · NIAMS · KAISER FOUNDATION RESEARCH INSTITUTE · PI HILLIER, TERESA A · 1986 to 2005
$3.2M
Study of Osteoporotic Fractures (SOF)R01AG027574 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI HILLIER, TERESA A · 2006 to 2015
$2.6M
Study of Osteoporotic Fractures (SOF)-Pittsburgh ClinicR01AG027576 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CAULEY, JANE ANN · 2006 to 2015
$2.4M
Study of Osteoporotic FracturesR01AR035582 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CAULEY, JANE · 1986 to 2005
$2.4M
Study of Osteoporotic FracturesR01AR035584 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI HOCHBERG, MARC C. · 1986 to 2005
$2.1M
CIHRMedical Research Council MR/P020941/1NIAMS NIH HHS R01 AR035582NIAMS NIH HHS R01 AR035583NIAMS NIH HHS R01 AR035584NIA NIH HHS R01 AG005394NIA NIH HHS R01 AG005407NIA NIH HHS R01 AG027574NIA NIH HHS R01 AG027576
6 · The paper itself

Abstract

objectiveWe aimed to assess whether individuals with type 2 diabetes (T2D) have increased risk of vertebral fractures (VFs) and to estimate nonvertebral fracture and mortality risk among individuals with both prevalent T2D and VFs. RESEARCH DESIGN AND

methodsA systematic PubMed search was performed to identify studies that investigated the relationship between T2D and VFs. Cohorts providing individual participant data (IPD) were also included. Estimates from published summary data and IPD cohorts were pooled in a random-effects meta-analysis. Multivariate Cox regression models were used to estimate nonvertebral fracture and mortality risk among individuals with T2D and VFs.

resultsAcross 15 studies comprising 852,705 men and women, individuals with T2D had lower risk of prevalent (odds ratio [OR] 0.84 [95% CI 0.74-0.95];

conclusionsBased on our findings, individuals with T2D should be systematically assessed for presence of VFs, and, as in individuals without T2D, their presence constitutes an indication to start osteoporosis treatment for the prevention of future fractures.

Indexed as

AgedAged, 80 and overBone DensityCohort StudiesDiabetes Mellitus, Type 2FemaleHumansMaleMiddle AgedOsteoporosisOsteoporotic FracturesSpinal Fractures

Identifiers

PMID31658976
PMCPMC7411280
OpenAlexW2981562883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.